Shares of Beleave Inc (TSE:BE) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.18 and last traded at C$0.00, with a volume of 0 shares trading hands.

In other Beleave news, Director Bojan Krasic purchased 60,000 shares of the business’s stock in a transaction on Tuesday, October 23rd. The shares were bought at an average cost of C$0.90 per share, for a total transaction of C$54,000.00. Also, Director Roger Emmanuel Ferreira sold 20,000 shares of the firm’s stock in a transaction on Thursday, August 23rd. The shares were sold at an average price of C$1.66, for a total value of C$33,200.00.

COPYRIGHT VIOLATION WARNING: “Beleave (BE) Sets New 52-Week Low at $0.18” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at

Beleave Company Profile (TSE:BE)

Beleave Inc, together with its subsidiaries, cultivates, produces, and sells tetrahydrocannabinol and cannabidiol medical cannabis in Canada and Colombia. The company produces cannabis oils and extracts for medical purposes. It also operates a network of medical cannabis clinics under the Medi-Green banner.

Featured Article: Exchange-Traded Funds (ETFs)

Receive News & Ratings for Beleave Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beleave and related companies with's FREE daily email newsletter.